[Aminoglycoside toxicity. Pathomechanisms, clinical management and means of prevention]

HNO. 2003 Apr;51(4):344-51; quiz 352. doi: 10.1007/s00106-003-0830-1.

[Article in German]

Authors

J Lautermann¹, J Schacht, K Jahnke

Affiliation

¹ Universitäts-Hals-, Nasen-,Ohrenklinik, Essen. ohn020@uni-essen.de

PMID: 12682739
DOI: 10.1007/s00106-003-0830-1

No abstract available

MeSH terms

AIDS-Related Opportunistic Infections / blood
AIDS-Related Opportunistic Infections / drug therapy*
Aminoglycosides
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / adverse effects*
Anti-Bacterial Agents / pharmacokinetics
Dose-Response Relationship, Drug
Drug Monitoring
Gram-Negative Bacterial Infections / blood
Gram-Negative Bacterial Infections / drug therapy*
Hearing Loss / blood
Hearing Loss / chemically induced*
Hearing Loss / prevention & control
Humans
Metabolic Clearance Rate / physiology
Renal Insufficiency / blood
Renal Insufficiency / chemically induced
Renal Insufficiency / prevention & control
Risk Factors
Tuberculosis, Multidrug-Resistant / blood
Tuberculosis, Multidrug-Resistant / drug therapy*
Vestibular Diseases / blood
Vestibular Diseases / chemically induced*
Vestibular Diseases / prevention & control

Substances

Aminoglycosides
Anti-Bacterial Agents